ICGA correlate with OCT findings for polypodal lesions

Article

Indocyanine green angiography (ICGA) correlate with OCT findings of polypoidal lesions in polypoidal choroidal vasculopathy.

Indocyanine green angiography (ICGA) correlate with OCT findings of polypoidal lesions in polypoidal choroidal vasculopathy, claims a study in the journal Retina.

An investigation led by Dr C. Ueno Department of Ophthalmology, Graduate School of Medicine, Osaka University, Osaka, Japan, involved 51 eyes of 51 patients with treatment-naive polypoidal choroidal vasculopathy. Each subject was administered intravitreal ranibizumab injections. Changes in polypoidal lesions on ICGA and OCT and their correlation over three months were recorded. Ranibizumab was injected again, determined by the presence of residual fluid on OCT.

ICGA detected 75 polypoidal lesions and all OCT lesions demonstrated baseline protrusion of the retinal pigment epithelium. Of the lesions, 49 persisted on ICGA, retinal pigment epithelium protrusion resolved in two lesions, decreased in four lesions, were stable in 36 lesions and increased in seven lesions.

It was discovered that polypoidal lesions persisted more often on OCT, even though ICGA and OCT presented with the same efficacy for ranibizumab.

To view the abstract click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.